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Abstract
Background: The present study highlights basic physiological differences associated with oocyte maturation and
ageing. The study explores the fertilizing capacity and resistance to injury of mouse oocytes at different stages of
maturation and ageing following IVF and ICSI. Also, the study examines the developmental competence of
embryos obtained from these oocytes. The outcome of the study supports views that the mouse can be a model
for human IVF suggesting that utilizing in-vitro matured and failed fertilized oocytes to produce embryos mainly
when limited number of oocytes is retrieved in a specific cycle, should be carefully considered.
Methods: Hybrid strain mouse oocytes were inseminated by in-vitro fertilization (IVF) or intracytoplasmic sperm
injection (ICSI). Oocytes groups that were used were germinal vesicle (GV) in-vitro matured metaphase II (IVM-
MII), freshly ovulated MII (OV-MII), 13 hrs in-vitro aged MII (13 hrs-MII) and 24 hrs in-vitro aged MII (24 hrs-MII).
Fertilization and embryo development to the blastocyst stage were monitored up to 5 days in culture for IVF and
ICSI zygotes. Sperm head decondensation and pronuclear formation were examined up to 9 hrs in oocytes
following ICSI. Apoptotic events in blocked embryos were examined using the TUNNEL assay. Differences
between females for the number and quality of GV and OV-MII oocytes were examined by ANOVA analyses.
Differences in survival after ICSI, fertilization by IVF and ICSI and embryo development were analysed by Chi-
square test with Yates correction.
Results: No differences in number and quality of oocytes were identified between females. The findings suggest
that inability of GV oocytes to participate in fertilization and embryo development initiates primarily from their
inability to support initial post fertilization events such as sperm decondensation and pronuclei formation. These
events occur in all MII oocytes in similar rates (87–98% for IVF and ICSI). Following ICSI, pronuclei appeared in
IVM and freshly ovulated oocytes by 8–9 hrs after insemination. In comparison, pronuclei appeared in 13 hrs aged
oocytes by 4–5 hrs. Significantly higher proportions (P < 0.001) of blastocysts resulted from OV-MII oocytes than
the other groups examined with 75% and 71% for IVF and ICSI, respectively. The 13 hrs-MII oocytes resulted in
47 and 40% blastocysts, while IVM-MII and 24 hrs-MII oocytes resulted in 38% and 0% blastocysts from IVF and
5% and 5% from ICSI, respectively. In addition, anucleate cells and DNA fragments were observed in retarded
embryos derived from IVM and aged oocytes, however, apoptotic events were similar for all groups.
Conclusion: The data suggests that the use of oocytes other than freshly ovulated MII should be carefully
considered for assisted reproduction.
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Background
Mammalian oocyte develops into a viable embryo follow-
ing fertilization, when sperm penetration takes place
within 4–6 hrs from ovulation. After this time, the capac-
ity of the oocyte to fertilize and to develop normally is
dramatically reduced [1,2]. Even though there are many
compiling evidence that freshly aspirated metaphase II
oocytes are the most optimal in producing viable
embryos, some IVF clinics around the world still utilize
in-vitro matured and failed fertilized oocytes to obtain
embryos.
Germinal vesicle (GV) stage oocytes have no ability to par-
ticipate in the early steps of fertilization. Although sperm
penetration has been reported in GV oocytes [3], sperm
head remodelling does not progress beyond slight swell-
ing. In many species, an increase in sperm remodelling
capability is acquired following a period of in-vitro matu-
ration [4-8]. It has been noted, however, that factors such
as follicle size, hormonal priming and the presence of fol-
licle stimulating hormone (FSH) in the culture medium
affect the rate of preimplantation development of IVM
oocytes [4,9]. Even so, developmental competence of
oocytes matured in-vitro is compromised in most species
investigated.
Problems in embryo development are also expected when
oocytes are inseminated after extend culture time. In mice,
oocytes that are inseminated or injected with sperm 24 hrs
or longer after retrieval from the oviducts have abnormal
calcium oscillation patterns leading to increased apopto-
sis and retarded embryo development [10,11]. These
events accelerate if oocytes are cumulus intact [12] and are
similar to events occurring when in-vivo aged mouse
oocytes are retrieved from the oviducts at 18.5 hrs after
ovulation [13].
The present study examines differences between imma-
ture, in-vitro matured, freshly ovulated and in-vitro aged
oocytes following in-vitro fertilization (IVF) and intracy-
toplasmic sperm injection (ICSI). The influence that mat-
uration stage and ageing of mouse oocytes has on
fertilization, resistance to injection, pronuclei formation
and embryo developmental competence to the blastocyst
stage was investigated. The study utilizes hybrid F1 mouse
strain, which has no developmental restrictions in culture
following in-vitro insemination, allowing the use of sim-
ple salt solutions as the culture medium. To avoid bias,
eggs were retrieved from same age females receiving simi-
lar hormonal treatments. Oocytes were retrieved from
females and exposed to same culture conditions and treat-
ments. The survival rate of the different oocytes to ICSI
was recorded and sperm head swelling and pronuclear
formation in intact oocytes were examined at different
times after ICSI. The capacity of the resultant zygotes to
develop to blastocysts on day 5 of culture and the chroma-
tin integrity and apoptotic events of retarded and normal
embryos on that day were examined by immunofluores-
cence.
Methods
Research plan
Female mice at 6 weeks of age were hormonally treated.
After the first hormonal injection, some females were used
to retrieve germinal vesicle (GV) oocytes obtained from
the ovaries. These oocytes were used either for IVF and
ICSI or cultured in-vitro for 13 hrs for spontaneous matu-
ration. This group is the in-vitro matured (IVM) oocyte
group. The rest of the females were subjected to a second
hormonal injection to induce ovulation. These females
were used to obtain freshly ovulated oocytes. Freshly ovu-
lated oocytes were either used for IVF and ICSI or left in-
culture to age for either 13 hrs or 24 hrs. Aged oocytes
were also used for IVF and ICSI. The above plan resulted
in five oocyte groups: GV, IVM-MII, OV-MII, 13 hrs-MII
and 24 hrs-MII.
Rational of the study
Total of 5 groups were included in the study attempting to
use similar groups that are used in IVF clinics to produce
embryos: 1) GV oocytes; 2) IVM oocytes (matured for 13
hrs in vitro); 3) Freshly ovulated MII oocytes; 4) 13 hrs in-
vitro aged oocytes; 5) 24 hrs in-vitro aged oocytes. These
groups represent pre mature, mature MII oocytes obtained
in-vivo and in-vitro, and in-vitro aged. Group 3 the freshly
ovulated MII oocytes is the control group. The outcome of
fertilization and embryo development of the other groups
was compared to this group.
Culture media
Solutions used in the study were prepared from analytical
grade chemicals (BDH Chemicals Pty., Ltd., Melbourne,
Australia; Sigma Chemicals Co., St. Louis. MO, US).
Sperm were collected and capacitated in modified
Tyrode's medium [14]. Oocytes and embryos were han-
dled in M2 medium [15] and cultured in M16 medium
[16].
Animals
Hybrid F1 (C57BLxCBA) mice were used for the experi-
ments. Animal protocols were approved by the Monash
University Animal Ethics Committee (SOBS-A) and con-
ducted under the Australian National Health and Medical
Research Council (NHMRC) code of practice.
Preparation of gametes
Oocytes
Six-week old females were given a single subcutaneous
injection of 10 IU Pregnant Mare's Serum Gonadotrophin
(PMSG, Folligon, Intervet, Lane Cove, Australia). ToReproductive Biology and Endocrinology 2008, 6:58 http://www.rbej.com/content/6/1/58
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obtain GV oocytes, females were killed 48 hrs after PMSG
injection and the dissected ovaries placed in 2 ml of M2
handling medium. Antral follicles were pierced with sharp
fine forceps to release the oocytes. Cumulus cells were
mechanically removed. Denuded GV oocytes were trans-
ferred into 20 μl drops of M16 culture medium until they
were used for injection or insemination. For spontaneous
IVM, cumulus intact and cumulus free GV oocytes were
collected and cultured in M16 medium for 12–13 hrs. At
that time oocytes were exposed to 100 IU/ml hyaluroni-
dase in M2 medium (Type IV-S, Sigma Chemicals Co., St.
Luis, Mo., USA) for 5 min to allow cumulus cells to sepa-
rate from the oocytes. Oocytes that extruded the first polar
body were considered to have matured to MII stage. These
IVM-MII oocytes were washed in M2 free of hyaluronidase
and were subjected to IVF and ICSI. To obtain OV-MII
oocytes, females were injected subcutaneously with
human Chorionic Gonadotrophin (hCG, Chorulon,
Intervet) 48 hrs after the PMSG injection. At 12–13 hrs
after hCG injection the females were killed and the cumu-
lus oocyte complexes were released from the oviducts into
M2 medium containing to100 IU/ml hyaluronidase to
allow cumulus cells to separate from the oocytes. Oocytes
washed of adhering cumulus cells were injected or insem-
inated with sperm. To obtain aged oocytes, cumulus free
OV-MII were cultured in M16 for either 12–13 hrs or 23–
24 hrs, before IVF and ICSI.
Sperm
Sperm were obtained from the cauda epididymes of 8 to
10 week old F1 males. One cauda was dissected out from
the body and transferred into previously equilibrated
(37°C at 5% CO2 in air) 2 ml MT6 medium under a thin
layer of mineral oil (Sigma). Sperm were passively
released into the culture medium through a single slit in
the base of the cauda. Sperm were capacitated for 2 hrs
before IVF and ICSI.
In vitro fertilization (IVF), intracytoplasmic sperm injection 
(ICSI) and embryo development
For IVF, oocytes were placed in sperm suspension for 3 hrs
and then washed and cultured in M16 medium for further
analyses. For ICSI, oocytes were injected using a Piezo
injection system (PiezoDrill, Burleigh Instrument Inc.,
Burleigh Park, NY, USA) mounted on a Leica microman-
ipulator (Leica Microscopy Systems Ltd, Wetzler, Ger-
many) adjacent to a Leica inverted microscope. Sperm
were selected randomly and the sperm heads were sepa-
rated from the tails using a high Piezo pulse before they
were injected singly into each oocyte [17]. Intact oocytes
were cultured in 20 μl drops of M16 medium under oil at
37°C in 5% CO2 in air. The number of IVF and ICSI
oocytes that had extruded a second polar body and had
two pronuclei visible 9 hrs after insemination or injection
was recorded. Oocytes with no second polar body and no
pronuclei were considered not fertilized. The develop-
ment of zygotes to blastocysts on day 5 of culture was
recorded.
Formation of pronuclei
In a separate experiment, oocytes at 1–2, 4–5 and 8–9 hrs
after ICSI (n = 15 for each oocyte age and time groups)
were placed on 70% ethanol washed glass slides and
allowed to air dry at room temperature for 3–5 min before
they were immersed in 100% methanol repeatedly.
Oocytes were stained with 4'6-Diamidino-2-phenyiodole
dilactate (DAPI; Roche Applied Science, Castle Hill, Aus-
tralia) dissolved (1:1000) in anti fade Vectashield mount-
ing medium (Vector laboratories Inc., Burlingame, USA).
The slides were examined at absorption and emission
wave lengths of 344 nm and 450 nm, respectively, using
an Olympus 1 × 70 inverted fluorescent microscope
(Olympus Optical Co., Tokyo, Japan).
Analyses of chromatin integrity and apoptosis
Embryos that were blocked in cleavage and morphologi-
cally normal blastocysts on day 5 after IVF or ICSI were
fixed on a glass slides using 4% paraformaldehide in pH
7.4 PBS (w/v). Oocytes were examined by the TUNEL
assay using the ApopTag plus Fluorescein In Situ Apopto-
sis Detection Kit (Chemicon International Inc., Temecula,
CA) as per manufacturer instructions. Embryos were
counterstained with DAPI. A positive apoptosis event was
recorded when DNA stained with DAPI was found also to
be positive for dUDP nick identified by the fluorescent
marker FITC.
Statistical analyses
Differences between females used for the experiments in
relation to ovulation and quality of oocytes were analysed
by ANOVA. Survival, fertilization and embryo develop-
ment data were analysed by Chi-square (χ2) using Yates'
correction for samples less than 50. Chi-square test was
used to compare the total number between two groups or
among several experimental groups. P values of 0.05 or
less were considered significant.
Results
Fertilization and embryo development
Hormonal treatment resulted in an average of 20 oocytes
from each female used with no differences identified
between females. A total of 151, 115, 151, 173, 214
oocytes at the GV, IVM-MII, OV-MII, 13 hrs-MII and 24
hrs-MII stages were inseminated with sperm, respectively.
Only one GV oocyte showed signs of fertilization 9 hrs
after insemination. It was difficult to identify clear signs of
fertilization in the 24 hrs-MII oocytes as most underwent
spontaneous cleavage or fragmentation within 1–2 hrs
from insemination. Fertilization rates for IVM-MII, OV-
MII and 13 hrs-MII oocytes were 82%, 94% and 98%,Reproductive Biology and Endocrinology 2008, 6:58 http://www.rbej.com/content/6/1/58
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respectively (Table 1). The fertilization rate in the IVM-
MII group was significantly lower than ovulated and 13
hrs-MII oocytes (P < 0.001). None of the GV or 24 hrs-MII
oocytes developed to the blastocyst stage in culture. The
blastocyst rate was significantly higher in the OV-MII
group of oocytes (P < 0.001) when compared to rates of
IVM-MII and 13 hrs-MII aged oocytes (Table 1).
Totals of 173, 195, 236, 251 and 230 oocytes at the GV,
IVM-MII, OV-MII, 13 hrs-MII and 24 hrs-MII aged stages
were injected with a single spermatozoon. The survival
rate of oocytes following injection increased gradually
with maturation and ageing, and was the highest for 24
hrs-MII oocytes (80%). Except for GV oocytes, over 90%
of the IVM-MII, OV-MII and 13 hrs-MII oocytes were fer-
tilized. Similar to IVF, after ICSI it was difficult to identify
fertilization in 24 hrs-MII oocytes as most cleaved sponta-
neously within 1 to 2 hrs from injection. IVM-MII, OV-
MII and 13 hrs-MII oocytes cleaved to 2-cells at rates of
79% (n = 72), 89% (n = 133) and 90% (n = 139), respec-
tively (Table 2). OV-MII oocytes had significantly higher
cleavage rate than IVM-MII (38%; P < 0.05) and 13 hr-MII
(47%; P < 0.05) oocytes. The development to blastocysts
following ICSI was also significantly higher (P < 0.001)
for OV-MII oocytes (71%, n = 106) than the other three
groups (5%, n = 5; 40%, n = 62 and 5%, n = 10 for IVM-
MII, 13 hrs-MII and 24 hrs-MII aged oocytes, respec-
tively). GV oocytes did not form pronuclei or cleave in
culture following ICSI.
As presented in figure 1a and 1b a low and constant
number of embryos derived from OV-MII oocytes stopped
cleaving at each stage of development in-vitro. IVM-MII
oocytes derived embryos had the highest proportions of
embryos that stoped at the 2-cell and morula/8 cell stages
following IVF (30% and 20%) and ICSI (50% and 70%).
The proportions of IVF embryos derived from 13 hrs-MII
oocytes that blocked in culture was gradually reduced
through development. The number of embryos in this
group that blocked at the second cell cycle (from 2-cells to
4-cells) was the highest when ICSI was used. The number
of embryos that blocked stayed relatively constant after
that point.
Pronuclei formation
A total of 10 oocytes from each of the experimental groups
were successfully analysed at 1–2, 4–5 and 8–9 hrs after
ICSI and DAPI staining. Sperm heads did not show any
changes within 1–2 hrs of ICSI in any of the groups. By 4–
5 hrs, most of sperm heads were visibly decondensed in
IVM-MII, OV-MII and 13 hrs-MII oocytes (Figure 2). In
most (8/10) 13 hrs-MII oocytes, pronuclei were already
visible by that time. At 8–9 hrs from injection, fully
formed male and female pronuclei were observed in 9/10
of IVM-MII oocytes, 10/10 OV-MII and 9/10 13 hrs-MII
oocytes (Figure 2). In all GV oocytes, sperm heads were
slightly swollen by 8–9 hrs with no change observed after
this. In these oocytes, the female chromatin remained
defuse (GVBD) and did not mature to metaphase. In 24
hrs-MII oocytes, pseudo-pronuclei appeared in 4/10
oocytes within 1–2 hrs after ICSI, while sperm heads were
still in a condensed form. Sperm heads were swollen by
4–5 hrs in 5/10 oocytes while female pronuclei were
already visible. Similar observations were recorded for 24
hrs-MII oocytes 8–9 hrs after ICSI. In this group only 2
oocytes had a second polar body and 2 clear pronuclei,
presumably a male and a female, while the rest had one
large pronucleus and either swollen sperm head or several
DNA patches within the cytoplasm. The second polar
body was not extruded from these oocytes leading to poly-
nucleated cytoplasm.
Chromatin integrity and apoptosis
Blocked embryos and embryos at the morula and blasto-
cyst stages after IVF and ICSI of IVM-MII, OV-MII,13 hrs-
MII and 24 hrs-MII oocytes were analysed by dUDP nick-
end labelling (TUNEL) markers and counterstained with
DAPI. The embryos showed a varying degree of DNA frag-
mentation. While blastocyst stage embryos in general had
1 or 2 cells with positive TUNEL results in all groups, the
majority of blocked embryos (Figure 3 and Figure 4) had
fragmented and scattered DNA, which was rarely associ-
ated with a positive TUNEL outcome. The frequency of
cell fragmentation without DNA was evident in embryos
derived from IVM-MII or 13 hrs-MII and 24 hr-MII
oocytes. However, in blocked embryos derived from IVM-
MII oocytes, most of the chromatin was found intact. Blas-
Table 1: Rates of pronuclei formation and development to morula and blastocysts of IVM, MII and aged oocytes following IVF.
IVM Ovulated 13 hr Aged
No. oocytes inseminated 115 151 173
No. oocytes with 2 PN/inseminated 94 (82%)a, b 142 (94%)a 169 (98%)b
2 cell embryos/inseminated 89 (77%)c 135 (89%)c, a 129 (75%)a
4 cell embryos/inseminated 61 (53%)a 126 (83%)a, b 98 (57%)b
8 cell embryos/inseminated 55 (48%)a 119 (79%)a, b 83 (48%)b
No. blastocysts/inseminated 44 (38%)a 114 (75%)a, b 82 (47%)b
Similar letters indicate statistical differences between groups of the same developmental stage
a, bp < 0.001; cp < 0.01Reproductive Biology and Endocrinology 2008, 6:58 http://www.rbej.com/content/6/1/58
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tocyst stage embryos from IVM-MII, OV-MII and 13 hrs-
MII had 1–2 cells with positive TUNEL labelling (Figure
5). Although no cell number was examined, blastocysts
derived from IVM-MII seemed smaller in size and with
fewer cells within them (Figure 5).
Discussion
The present study successfully detailed differences in
oocytes of different maturation and in-vitro age following
ICSI and IVF in their ability to form male and female pro-
nuclei, initiate embryo division cycles and development
to blastocysts in-vitro. We also identified differences in
oolemma stability related to maturation and aging. The
link between the ability of the cytoplasm to remodel the
sperm chromatin to form pronuclei, and the maturation
stage of oocytes, is well accepted. Studies in humans and
mice, including the present study, have shown that the
cytoplasm with the least ability to induce sperm
decondensation is the immature GV stage cytoplasm [3].
Sperm may penetrate GV, or maturing oocytes, but they
do not undergo detectable decondensation and the
plasma membrane remains intact. Sperm heads located
within maturing metaphase I oocytes undergo partial
decondensation, whereas, in mature MII oocytes they
complete the decondensation process.
In the present study, the swelling of the sperm and forma-
tion of pronuclei observed in IVM-MII, OV-MII and 13
hrs-MII oocytes did not correlate with the developmental
competence of these oocytes in-vitro. While step wise cul-
ture systems for in-vitro maturation of young oocytes has
been suggested to be most optimal [18], simple solutions
and mixture of simple solutions with more complex ones
in a 1:1 ratio, where found more supportive of oocyte
competence for IVM when oocytes retrieved after hormo-
nal induction [19]. In the present study we deliberately
used simple salt solution to eliminate corrections of in-
vitro maturation and ageing by complex solutions.
The capacity of IVM-MII oocytes to progress to the blasto-
cyst stage in-culture was more limited following ICSI. This
may be related to the increased incidence of abnormal
configuration of chromatin and meiotic spindles
observed in IVM mouse oocytes [20], or to the compro-
mised capacity of IVM-MII oocytes to be activated and ini-
tiate normal embryonic cell cycles, more so by ICSI than
by IVF. It is recognised that the oocyte is transcriptionally
silenced during maturation [21] so the increasing capacity
to remodel sperm chromatin must derive from post-trans-
lational activation of bioactive factors during maturation,
which become exaggerated in their ability to form pronu-
clei or even pseudo-pronuclei with ageing. In mice, the
absolute rate of protein synthesis decreases during matu-
ration in-vitro [22]. Injection of sperm directly into the
cytoplasm bypasses the oocyte activation mechanisms
that takes place following sperm-oocyte fusion [23].
Although this has no major effect on embryo develop-
ment when ovulated oocytes are used, the impact on IVM-
MII oocytes may be crucial. Similar observations have
been made in humans where fertilization rates increased
following IVM and ICSI but embryo quality, implantation
and pregnancy rates were significantly reduced, when
compared to IVF of IVM oocytes [24,25]. Similarly in the
present study, fewer blastocysts were obtained from ICSI
of IVM-MII oocytes, therefore limiting the number of
embryos that can be transferred and the resultant number
of live offspring. Calcium plays a role in the regulation of
diverse cellular functions including enhancement of
oocyte maturation and embryo development [26]. Dys-
function in calcium release and intracellular mobilization
may affect embryo developmental competence [27]. Not
only IVM-MII oocytes have reduced capacity to incorpo-
rate, release and use calcium efficiently [28], they also
have reduced mitochondrial polarization [18]. Abnormal
function of the mitochondria may lead to suboptimal ATP
resulting in developmental incompetence related to
energy deficiency as clearly evident in IVM-MII oocytes.
Oocytes found to be more resilient to injury with matura-
tion and in-vitro ageing. The well documented phenome-
non of zona hardening [29,30] is not related to oocyte
maturation stage but to the length of oocyte culture in-
Table 2: Rates of survival, pronuclei formation and development to morulae and blastocysts of IVM, MII and aged oocytes following 
ICSI.
IVM Ovulated 13 hr Aged
No oocytes injected 195 263 251
No. oocytes survived 91 (47%)a, b, d 149 (57%)a, d 155 (62%)a, b
2 PN 89 (98%) 141 (95%) 145 (94%)
2-cells/survived 72 (79%)a, c 133 (89%)a 139 (90%)c
4-cells/survived 34 (37%)c 122 (82%)c 107 (69%)c
8-cells/survived 16 (18%)a 116 (78%)a 81 (52%)a
No. blastocysts/survived 5 (5%)a 106 (71%)a 62 (40%)a
Similar letters indicate statistical differences between groups of the same developmental stage
ap < 0.001; bp,0.005; cp < 0.01; dp,0.05Reproductive Biology and Endocrinology 2008, 6:58 http://www.rbej.com/content/6/1/58
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Blockage rate of embryos following IVF (a) and ICSI (b) of embryos obtained from IVM, freshly ovulated and 13 hr aged oocytes Figure 1
Blockage rate of embryos following IVF (a) and ICSI (b) of embryos obtained from IVM, freshly ovulated and 
13 hr aged oocytes.
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Pronuclei formation at 4–5 and 8–9 hrs after ICSI of IVM, freshly ovulated and 13 hrs aged oocytes injected at different matu- ration stages Figure 2
Pronuclei formation at 4–5 and 8–9 hrs after ICSI of IVM, freshly ovulated and 13 hrs aged oocytes injected at 
different maturation stages. Oocytes were injected with a single sperm head. Oocytes were fixed and stained with DAPI at 
different times after injection. SC = sperm chromatin; EC = egg chromatin; PN = pronuclei; PB = polar body.
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Blocked embryos derived from 24 hrs in-vitro aged oocytes after ICSI Figure 3
Blocked embryos derived from 24 hrs in-vitro aged oocytes after ICSI. Scattered DNA is observed in all embryos. 
Embryos 3a, 3c, and 3e are not associated with positive TUNEL assay (3b, 3d, 3f). Most embryos contain cell fragments, empty 
of chromatin. Embryo 3 g has some cells with clear apoptotic (Ap) events identified by the TUNEL assay (3h). Left panel: bright 
field. Right field: fluorescence images for DAPI and FITC to detect DNA and positive TUNEL.
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Blocked embryos derived from IVM oocytes after ICSI Figure 4
Blocked embryos derived from IVM oocytes after ICSI. Scattered DNA and DNA breakages is not obvious. All 
embryos have blastomeres that are empty of chromatin. Left panel: bright field. Right field: fluorescence images for DAPI and 
FITC to detect DNA and positive TUNEL.
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Blastocyst stage embryos developed from IVM oocytes (5a, b), 13 hrs aged oocytes (5c, d) and from freshly ovulated oocytes  after ICSI (5e, f) Figure 5
Blastocyst stage embryos developed from IVM oocytes (5a, b), 13 hrs aged oocytes (5c, d) and from freshly 
ovulated oocytes after ICSI (5e, f). Some cells within blastocysts in all groups were positive (Apo) to the TUNEL assay 
indicating apoptotic events. Left panel: bright field. Right field: fluorescence images for DAPI and FITC to detect DNA and pos-
itive TUNEL.Reproductive Biology and Endocrinology 2008, 6:58 http://www.rbej.com/content/6/1/58
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vitro. Here we observed oolemma stability with matura-
tion and ageing. The capacity to reseal the plasma mem-
brane is associated with the intracellular membrane
(endomembrane) and is a calcium dependent mechanism
[31]. Calcium is required in the external environment for
the resealing of the plasma membrane after ICSI. In GV
and some IVM oocytes, the calcium channels responsible
for calcium import from external sources (voltage-
dependent, N-type and L-type) are not uniformly distrib-
uted in the membrane when compared to freshly ovulated
oocytes [32]. The distribution of these channels is rear-
ranged during maturation from localised fractions to a
uniformed distribution. These channels are active at the
early cleavage stages of embryo development up until the
blastocyst stage where they disappear [32]. An inability to
efficiently import calcium to the site of injury will result
in cell death. This was evident in GV oocytes. Nonetheless,
resistance to injury is not related to the capacity of the
oocyte to complete development to blastocysts. Aged
oocytes which displayed high survival rate after ICSI did
not necessarily developed to blastocysts at high rates.
Embryos from 24 hrs-MII oocytes are either parthenog-
enones or polyspermic. In this group, formation of female
pronuclei in most oocytes occurred before sperm nuclei
underwent decondensation and there was no second
polar body extrusion. It is also known that aged oocytes
are less capable of blocking polyspermy [33]. Hence,
abnormal development may also be due to polyspermia
following IVF. Other abnormalities associated with aged
oocytes are related to calcium metabolism. In in-vivo aged
mouse oocytes obtained from the oviducts at 18.5 hr after
hCG injection the frequency of calcium oscillations fol-
lowing fertilization significantly increases compare to
freshly ovulated (12.5 hr post hCG injection) mouse
oocytes [10,13]. However, the amplitudes of the oscilla-
tions are smaller than in freshly ovulated oocytes. Aged
oocytes are unable to appropriately regulate ATP levels
following fertilization as a result of exposure of the posto-
vulatory oocytes to prolonged oxidative stresses within
the oviducts or prolonged in-vitro cultures as in the
present study [34]. The calcium signal following fertiliza-
tion and activation of mouse 24 hrs aged oocytes results
in the activation of caspase, a sign of apoptosis and coin-
cidently, the antiapoptotic Bcl-2 protein is reduced. In our
study we identified empty cell fragments evident in
embryos derived from IVM-MII and excessively aged
oocytes (24 hrs-MII). This may be due to the significant
differences in spindle position and distribution in IVM
and aged 24 hrs oocytes when compared to freshly ovu-
lated oocytes [35,36]. As a consequence this results, in
high proportion of aneuploidy [37]. Similar to the obser-
vations by Van Blerkom and Davis [38], who examined
apoptosis in aged unfertilised oocytes up to 5 days, DNA
fragmentation within cellular fragments of embryos that
resulted from 24 hrs aged oocytes or blocked/fragmented
embryos from all the groups were rarely associated with
positive dUDP nick-end labelling (TUNEL) marker. Van
Blerkom and Davis [38] identified TUNEL positive frag-
ments under the zona pellucida, which were likely to be
related to fragmentation of the first polar body. It may be
that identifying caspase activity [10,39] within blocked
and fragmented mouse embryos is a more accurate way to
predict programmed cell death.
Oocytes that were aged for 13 hrs only did not reach the
blastocyst stage at similar rates to OV-MII oocytes. These
oocytes are part-way through the aging process and they
start losing control over calcium and other metabolic
pathways. Low fertilization and pregnancy rates using
human oocytes reinseminated by ICSI, 25 hrs after oocyte
collection has also been reported in the past [40-42].
When human oocytes are rescued 19–22 hrs after retrieval
[43], fertilization, embryo development and pregnancy
rates are relatively higher than oocytes rescued at 24–30
hrs after retrieval [40-42]. Even better outcome is estab-
lished when human oocytes are rescued 9 hrs from egg
retrieval [44].
In addition to the ageing period, culture media, storage
temperature and atmosphere have a strong relationship to
developmental competence of aged oocytes [11]. Keeping
24 hrs old mouse oocytes in darkness at room tempera-
ture in simple solution such as modified Kreb-Ringer
bicarbonate known as TYH medium, allows a limited
ability to retain full developmental potential [11].
Although simple solution was used in the present study to
age oocytes for 24 hrs, they were kept in 37°C. Even if
their capacity to progress in embryonic development will
be maintained, few reports indicate that post ovulatory
ageing is associated with abnormal gene expression and
epigenetic alternations [45,46].
Conclusions
Physiological differences are evident between oocytes at
different maturation and ageing stages. These, no doubt-
fully are associated with biological processes taking place
during maturation and ageing. More importantly is the
clear acknowledgement of the superiority of freshly ovu-
lated MII mouse oocytes over IVM-MII or aged MII
oocytes, in relation to developmental competence.
Attempts to advance development by culture conditions
that may improve maturation and slow aging in-vitro,
results in only a small enhancement of embryo develop-
ment in the mouse [10]. This may raise concerns when
IVM oocytes and aged (mainly failed fertilized) oocytes
are used in human IVF or for nuclear transfer to form
embryonic stem cells [44-47].
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